Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Societal CDMO was a leading US-based contract development and manufacturing organization specializing in small molecule pharmaceuticals. The company provided end-to-end services including formulation development, analytical support, regulatory assistance, cGMP clinical and commercial manufacturing—including specialized capabilities for modified-release dosage forms and DEA controlled substances—packaging and logistics. It operated facilities in Gainesville, Georgia and San Diego, California totaling approximately 145,000 square feet. In April 2024 it was acquired by CoreRx to form an expanded entity focused on small molecule drug product development and manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Societal CDMO.